Firas Al Hawari

Chief, Cancer Control Officer ,Chief, Section of Pulmonary and Critical Care

Education and Training

M.B./B.S.
Fellowship, Pulmonary/Critical Care, University of California, Irvine, USA
Fellowship, Clinical Pharmacology, State University of New York, Millard Fillmore Hospital, USA
Resident, Internal Medicine, State University of New York, Millard Fillmore Hospital, USA

Board Certifications

ABIM, Critical Care Medicine
ABIM, Pulmonary Diseases
Physician in Management
ABIM, Pulmonary Diseases
American Board of Clinical Pharmacology
ABIM, Internal Medicine

Experience

2018-Present Chief, Cancer Control Officer, King Hussein Cancer Center (KHCC), Jordan
2004-Present Chief, Pulmonary/Critical Care, KHCC, Jordan
2013-Present Executive Council (Permanent Member), KHCC, Jordan
2006-2008 Executive Council Member, KHCC, Jordan
2006-2007 Chairman, Institutional Review Board, KHCC, Jordan
2000-2004 Senior Staff Fellow, Pulmonary/Critical Care, Pulmonary – Critical Care Medicine Branch NHLBI, National Institutes of Health, USA
2000-2004 Consultant, Pulmonary/Critical Care, Suburban Hospital (Bethesda, MD), USA

Professional Memberships

Associate Editor, Tobacco Regulatory Science Journal
World Health Organization (WHO) expert consultant on cancer control
International Atomic Energy Agency (IAEA) expert consultant on cancer control (ImPACT mission Lebanon 11/2013)
Temporary Advisor for the World Health Organization for the new advisory note on waterpipe tobacco smoking, Cairo 2014
Fellow of the American College of Chest Physicians (FCCP)
Regional Director, Global Bridges Healthcare Alliance, Eastern Mediterranean Region
Member, Management Board Treatobacco.net
Member, Jordan Medical Council Pulmonary Diseases Examination Committee
Member, National Anti-Tobacco Committee

Awards And Honors

2016 Judy Wilkenfeld Award for International Tobacco Control Excellence
Dexter Levy Memorial Award of “Excellence in Bedside Medicine”

Publications

ICU readmission of patients with cancer: Incidence, risk factors and mortality. AbuSara AK, Nazer LH, Hawari FI. J Crit Care. 2019 Feb 7;51:84-8.
Occurrence and molecular characterization of metallo-β-lactamases (MBLs) among Acinetobacter baumannii isolates from cancer patients. QouzahF, F Hawari, LF Abu-Qatouseh, AA Shehabi. The International Arabic Journal of Antimicrobial Agents. 2018 Vol. 8 No. 2:1 doi: 10.3823/821.
Reclaiming the value of pictorial health warning labels in Jordan.Obeidat NA, Al-Hadid M, Hatoqai AA, Shihab RA, Hawari FI. Tob Control. 2018 Sep;27(5):589-591.
Recommendations for the implementation of WHO Framework Convention on Tobacco Control Article 14 on tobacco cessation support. Raw M, Ayo-Yusuf O, Chaloupka F, Fiore M, Glynn T, Hawari F, Mackay J, McNeill A, Reddy S. Addiction. 2017 Aug 2.
Informing tobacco control policy in Jordan: assessing the effectiveness of pictorial warning labels on cigarette packs. Bader RK, Shihab RA, Al-Rimawi DH, Hawari FI. BMC Public Health. 2017 Aug 1;18(1):84.
Coverage of tobacco control in Jordanian newspapers: implications for strengthening the role of news media. Rasha K. Bader, Aisha S. Shtaiwi, Rawan A. Shihab 1, Nour A. Obeidat and Feras I. Hawari. EMHJ • Vol. 23 No. 5 • 2017.
The effect of habitual waterpipe tobacco smoking on pulmonary function and exercise capacity in young healthy males: A pilot study. Two Points To Highlight. Hawari FI. Respir Med. 2017 Mar;124:102. doi: 10.1016/j.rmed.2017.02.006. Epub 2017 Feb 11.
Influencing readiness and intentions to offer tobacco dependence treatment through training: King Hussein Cancer Center and Global Bridges promoting an underutilized specialty in the Eastern Mediterranean Region. Feras I. Hawari, Rasha K. Bader, Nour A. Obeidat,1 Hiba S. Ayub,1 Iyad M. Ghonimat, J. Taylor Hays, and Richard D. Hurt. Journal of Smoking Cessation, 2016. doi:10.1017/jsc.2016.17.
Educational Needs of Oncology Practitioners in a Regional Cancer Center in the Middle East—Improving the Content of Smoking Cessation Training Programs. NA Obeidat, FI Hawari, R Amarin, BA Altamimi, IM Ghonimat. J Cancer Educ. 2016 Mar 8.
Predictors of ICU Admission in Patients With Cancer and the Related Characteristics and Outcomes: A 5-Year Registry-Based Study. FI Hawari, LH Nazer, A Addassi, D Rimawi, K Jamal. Critical care medicine. 2016 Mar;44(3):548-53.
Advancing tobacco dependence treatment services in the Eastern Mediterranean Region: international collaboration for training and capacity building. Hawari FI, Bader RK. Sultan Qaboos Univ Med J. 2014 Nov;14(4):e442-7.
Smoking Cessation Treatment and Outcomes in Medium to Heavy Cigarette Smokers being Treated for Cancer in Jordan. Hawari FI, Obeidat NA, Ayub HS, Dawahrah SS, Hawari SF. Asian Pac J Cancer Prev. 2013;14(11):6875-81. PMID: 24377503.
The acute effects of water-pipe smoking on lung function and exercise capacity in a pilot study of healthy participants. Hawari FI, Obeidat NA, Ayub H, Ghonimat I, Eissenberg T, Dawahrah S, Beano H. Inhal Toxicol. 2013 Aug;25(9):492-7.
Smoking Cessation in Cancer Patients in Jordan: Abstinence Rates and Reasons for Failure to Quit Smoking. Hawari F, Obeidat N, Beano H, Dawahrah S, Al-Rimawi D, Ghonimat I. Respiration. 2011 Jun 22. 2012;83(3):233-8.
The Effect of Implementing High-Intensity Intensive Care Unit Staffing Model on Outcome of Critically Ill Oncology Patients. Feras I. Hawari MD, Taghreed I. Al Najjar MD, Luna Zaru PhD, Wa’ed Al Fayoumee RN, Samer H. Salah MD, Mohammad Z. Mukhaimar MD Critical Care Medicine, 2009 Jun; 37(6):1967-71.
Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Hawari FI, Rouhani FN, Cui X, Yu ZX, Buckley C, Kaler M, Levine S.J. Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5): 1297-302.
Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, Rouhani FN, Miskinis D, Levine S.J. J Clin Invest 2002 Aug; 110(4): 515-26.
Heparin attenuates norepinephrine-induced venoconstriction. Feras I. Hawari, MBBS, Barbara Shykoff, PhD, Joseph L. Izzo, MD.Vascular Medicine, 395-100, Dec1998.

Contact Information

Email Address: fhawari@khcc.jo
Phone Number: 0096265300460-5240